Your browser doesn't support javascript.
loading
Targets for Ibrutinib Beyond B Cell Malignancies.
Berglöf, A; Hamasy, A; Meinke, S; Palma, M; Krstic, A; Månsson, R; Kimby, E; Österborg, A; Smith, C I E.
Afiliação
  • Berglöf A; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Hamasy A; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Meinke S; Center for Hematology and Regenerative Medicine, Karolinska Institutet, and Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Palma M; Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Krstic A; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Månsson R; Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Kimby E; Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Österborg A; Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Smith CI; Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden.
Scand J Immunol ; 82(3): 208-17, 2015 Sep.
Article em En | MEDLINE | ID: mdl-26111359

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoclastos / Pirazóis / Pirimidinas / Proteínas Tirosina Quinases / Transtornos Linfoproliferativos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Scand J Immunol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoclastos / Pirazóis / Pirimidinas / Proteínas Tirosina Quinases / Transtornos Linfoproliferativos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Scand J Immunol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suécia